At a glance
ClinicalIndex Comparison RecordN/ACompleted· 123 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Study With PASCALLERG ® in Patients With Hay Fever
In Brief
An observational study for Hay Fever. Completed, enrolled 123 participants across 1 site.
Detailed Summary
The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHay Fever
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
First PostedAug 2012
Primary CompletionJul 2013
TodayJul 2026
First PostedAug 9, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 13.9 years ago